ARTICLE | Clinical News
Peptide regulatory update
July 29, 1996 7:00 AM UTC
PTD received notices of allowance for two U.S. patents and a European patent. One U.S. patent covers GMDP, PTD's immunomodulating peptide, to treat inflammatory conditions associated with infection. G...